Recruiting
Phase 1
Phase 2

A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas

Sponsor:

Dren Bio

Code:

NCT05475925

Conditions

LGLL - Large Granular Lymphocytic Leukemia

Primary Cutaneous T-Cell Lymphoma - Category

Primary Cutaneous CD8-Positive Aggressive Epidermotropic T-Cell Lymphoma

Hepatosplenic T-cell Lymphoma

Subcutaneous Panniculitis-Like T-Cell Lymphoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

DR-01

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information